Min G. Jo

Waegwan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

IL-10-producing innate lymphoid cells restrain γδT17-driven psoriatic inflammation.

IL-10-producing innate lymphoid cells restrain γδT17-driven psoriatic inflammation.

Journal: iScience

Published: February 10, 2026

Peritoneal mast cell-derived IL-10 promotes peritoneal-colon tolerance by reprogramming macrophages to ameliorate colitis.

Peritoneal mast cell-derived IL-10 promotes peritoneal-colon tolerance by reprogramming macrophages to ameliorate colitis.

Journal: Scientific reports

Published: November 24, 2025

Pluviatolide Attenuates Type I Hypersensitivity through Regulation of Mast Cell Activation.

Pluviatolide Attenuates Type I Hypersensitivity through Regulation of Mast Cell Activation.

Journal: Biomolecules & therapeutics

Published: August 26, 2025

Antimicrobial Peptide Pro10-1D Exhibits Anti-Allergic Activity: A Promising Therapeutic Candidate.

Antimicrobial Peptide Pro10-1D Exhibits Anti-Allergic Activity: A Promising Therapeutic Candidate.

Journal: International journal of molecular sciences

Published: October 09, 2024

IL-10+ regulatory B cells mitigate atopic dermatitis by suppressing eosinophil activation.

IL-10+ regulatory B cells mitigate atopic dermatitis by suppressing eosinophil activation.

Journal: Scientific reports

Published: May 29, 2024

Drug repositioning of anti-microbial agent nifuratel to treat mast cell-mediated allergic responses.

Drug repositioning of anti-microbial agent nifuratel to treat mast cell-mediated allergic responses.

Journal: International journal of immunopathology and pharmacology

Published: September 14, 2023

IL-27-induced PD-L1highSca-1+ innate lymphoid cells suppress contact hypersensitivity in an IL-10-dependent manner.

IL-27-induced PD-L1highSca-1+ innate lymphoid cells suppress contact hypersensitivity in an IL-10-dependent manner.

Journal: Experimental & molecular medicine

Published: April 18, 2023

AT9283, 1-Cyclopropyl-3-(3-(5-(Morpholinomethyl)-1H-Benzo[d]Imidazole-2-yl)-1H-Pyrazol-4-yl) Urea, Inhibits Syk to Suppress Mast Cell-Mediated Allergic Response.

AT9283, 1-Cyclopropyl-3-(3-(5-(Morpholinomethyl)-1H-Benzo[d]Imidazole-2-yl)-1H-Pyrazol-4-yl) Urea, Inhibits Syk to Suppress Mast Cell-Mediated Allergic Response.

Journal: Biomolecules & therapeutics

Published: March 24, 2022

Percutaneous radiofrequency ablation of hepatocellular carcinoma in a recent cohort at a tertiary cancer center: incidence and factors associated with major complications and unexpected hospitalization events.

Percutaneous radiofrequency ablation of hepatocellular carcinoma in a recent cohort at a tertiary cancer center: incidence and factors associated with major complications and unexpected hospitalization events.

Journal: Ultrasonography (Seoul, Korea)

Published: March 12, 2022

CD1dhiPD-L1hiCD27+ Regulatory Natural Killer Subset Suppresses Atopic Dermatitis.

CD1dhiPD-L1hiCD27+ Regulatory Natural Killer Subset Suppresses Atopic Dermatitis.

Journal: Frontiers in immunology

Published: August 03, 2021

Entinostat, a histone deacetylase inhibitor, increases the population of IL-10+ regulatory B cells to suppress contact hypersensitivity.

Entinostat, a histone deacetylase inhibitor, increases the population of IL-10+ regulatory B cells to suppress contact hypersensitivity.

Journal: BMB reports

Published: July 13, 2021

Dasatinib Inhibits Lyn and Fyn Src-Family Kinases in Mast Cells to Suppress Type I Hypersensitivity in Mice.

Dasatinib Inhibits Lyn and Fyn Src-Family Kinases in Mast Cells to Suppress Type I Hypersensitivity in Mice.

Journal: Biomolecules & therapeutics

Published: January 30, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026